Treatment with Diminazene aceturate, a putative ACE2 activator, reduces immunopathology in severe SARS-CoV-2 and influenza virus infections (#16)
Melanie Wu
1
,
Kirsten Ignacio
1
,
Julian Sng
1
,
Ellesandra Noye
1
,
Georgina Megan McCallum
1
,
Helle Bielefeldt-Ohmann
1
,
Keng Yih Chew
1
,
Kirsty Short
1
- School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD, Australia